SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Oliver Königsbrügge, Silvia Koder, Julia Riedl, Simon Panzer, Ingrid Pabinger, Cihan Ay, A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability, Clinical and Experimental Medicine, 2016,

    CrossRef

  2. 2
    Anita Kern, Attila Balog, Sonja Dulic, Eszter Barabás, Mária Kiszelák, Barna Vásárhelyi, Alterations of the thrombin generation profile in rheumatoid arthritis, Journal of Thrombosis and Thrombolysis, 2016, 41, 3, 359

    CrossRef

  3. 3
    Ibrahim O. Balogun, Lara N. Roberts, Raj Patel, Rohan Pathansali, Lalit Kalra, Roopen Arya, Clinical and laboratory predictors of deep vein thrombosis after acute stroke, Thrombosis Research, 2016, 142, 33

    CrossRef

  4. 4
    Michael B. Streiff, Giancarlo Agnelli, Jean M. Connors, Mark Crowther, Sabine Eichinger, Renato Lopes, Robert D. McBane, Stephan Moll, Jack Ansell, Guidance for the treatment of deep vein thrombosis and pulmonary embolism, Journal of Thrombosis and Thrombolysis, 2016, 41, 1, 32

    CrossRef

  5. 5
    F. Abu Saadeh, R. Langhe, D.M. Galvin, S.A. O Toole, D.M. O'Donnell, N. Gleeson, L.A. Norris, Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy, Thrombosis Research, 2016, 139, 135

    CrossRef

  6. 6
    Nuri Lee, Ji-Eun Kim, Ja-Yoon Gu, Hyun Ju Yoo, Inho Kim, Sung-Soo Yoon, Seonyang Park, Kyou-Sup Han, Hyun Kyung Kim, Protein Z efficiently depletes thrombin generation in disseminated intravascular coagulation with poor prognosis, Blood Coagulation & Fibrinolysis, 2016, 27, 1, 84

    CrossRef

  7. 7
    Unity Jeffery, Janice Staber, Dana LeVine, Using the laboratory to predict thrombosis in dogs: An achievable goal?, The Veterinary Journal, 2016,

    CrossRef

  8. 8
    Elena N Lipets, Fazoil I Ataullakhanov, Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk, Thrombosis Journal, 2015, 13, 1, 4

    CrossRef

  9. 9
    O. Espitia, M. Fouassier, Le test de génération de thrombine, La Revue de Médecine Interne, 2015, 36, 10, 690

    CrossRef

  10. 10
    Wilma Potze, Robert J Porte, Ton Lisman, Management of coagulation abnormalities in liver disease, Expert Review of Gastroenterology & Hepatology, 2015, 9, 1, 103

    CrossRef

  11. 11
    Michael B. Streiff, Predicting the risk of recurrent venous thromboembolism (VTE), Journal of Thrombosis and Thrombolysis, 2015, 39, 3, 353

    CrossRef

  12. 12
    Seon Young Kim, Ji-Eun Kim, Yoon Jun Kim, Kyou-Sup Han, Hyun Kyung Kim, Prominent protein Z-induced thrombin inhibition in cirrhosis: A new functional assay for hypercoagulability assessment, Journal of Gastroenterology and Hepatology, 2015, 30, 4
  13. 13
    Hilda Luna-Záizar, Ana Isabel González-Moncada, Emily Lizbeth Padilla-López, Ana Cristina Ramírez-Anguiano, Fermín Paul Pacheco-Moisés, Sandra Fabiola Velasco-Ramírez, María Guadalupe Zavelia Padilla-Romo, Cesar Borjas-Gutierrez, Ana Rebeca Jaloma-Cruz, Thrombin generation and international normalized ratio in inherited thrombophilia patients receiving thromboprophylactic therapy, Thrombosis Research, 2015, 136, 6, 1291

    CrossRef

  14. 14
    Alisa S. Wolberg, Frits R. Rosendaal, Jeffrey I. Weitz, Iqbal H. Jaffer, Giancarlo Agnelli, Trevor Baglin, Nigel Mackman, Venous thrombosis, Nature Reviews Disease Primers, 2015, 15006

    CrossRef

  15. 15
    A. Rocanin-Arjo, W. Cohen, L. Carcaillon, C. Frere, N. Saut, L. Letenneur, M. Alhenc-Gelas, A.-M. Dupuy, M. Bertrand, M.-C. Alessi, M. Germain, P. S. Wild, T. Zeller, F. Cambien, A. H. Goodall, P. Amouyel, P.-Y. Scarabin, D.-A. Tregouet, P.-E. Morange, A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential, Blood, 2014, 123, 5, 777

    CrossRef

  16. 16
    Valeria Rossetto, Luca Spiezia, Marco Senzolo, Krissia Isabel Rodriguez-Castro, Sabrina Gavasso, Barry Woodhams, Paolo Simioni, Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis?, Internal and Emergency Medicine, 2014, 9, 4, 397

    CrossRef

  17. 17
    F. Kovacs, Zs. Gerlei, D. Gorog, M. Varga, L. Kobori, I. Gaal, R.M. Langer, B.L. Beresne, E. Sarvary, Endogenous Thrombin Potential and Examination of a Further 31 Analytes in Liver Transplant Candidates, Transplantation Proceedings, 2014, 46, 6, 2171

    CrossRef

  18. 18
    Kathleen E. Brummel-Ziedins, Alisa S. Wolberg, Global assays of hemostasis, Current Opinion in Hematology, 2014, 21, 5, 395

    CrossRef

  19. 19
    Hyun Kyung Kim, Ji Eun Kim, So Hyun Park, Young Il Kim, Il Sung Nam-Goong, Eun Sook Kim, High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications, Journal of Diabetes and its Complications, 2014, 28, 3, 365

    CrossRef

  20. 20
    Joanne van Ryn, Oliver Grottke, Henri Spronk, Measurement of Dabigatran in Standardly Used Clinical Assays, Whole Blood Viscoelastic Coagulation, and Thrombin Generation Assays, Clinics in Laboratory Medicine, 2014, 34, 3, 479

    CrossRef

  21. 21
    Walid Saliba, Wael Zahalka, Lee Goldstein, Gilat Ron, Mazen Elias, Padua prediction score and thrombin generation in hospitalized medical patients, Thrombosis Research, 2014, 134, 4, 803

    CrossRef

  22. 22
    Kyunghoon Lee, Ji-Eun Kim, Jihyun Kwon, Inho Kim, Sung-Soo Yoon, Seonyang Park, Kyou-Sup Han, Hyun Kyung Kim, Poor prognosis of hypocoagulability assessed by thrombin generation assay in disseminated intravascular coagulation, Blood Coagulation & Fibrinolysis, 2014, 25, 3, 241

    CrossRef

  23. 23
    J. P. Vavalle, C. P. Rusconi, S. Zelenkofske, W. A. Wargin, T. L. Ortel, J. H. Alexander, T. J. Povsic, R. C. Becker, The effect of the REG2 Anticoagulation System on thrombin generation kinetics: a pharmacodynamic and pharmacokinetic first-in-human study, Journal of Thrombosis and Thrombolysis, 2014, 38, 3, 275

    CrossRef

  24. 24
    Sarah A. Bennett, Catherine N. Bagot, Adjoa Appiah, Jemma Johns, Jackie Ross, Lara N. Roberts, Raj K. Patel, Roopen Arya, Women with unexplained recurrent pregnancy loss do not have evidence of an underlying prothrombotic state: Experience with calibrated automated thrombography and rotational thromboelastometry, Thrombosis Research, 2014, 133, 5, 892

    CrossRef

  25. 25
    Lara N. Roberts, Raj K. Patel, Paradzai Chitongo, Lynda Bonner, Roopen Arya, African–Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation, Blood Coagulation & Fibrinolysis, 2013, 24, 1, 40

    CrossRef

  26. 26
    L. Tarantini, M. Bonzini, A. Tripodi, L. Angelici, F. Nordio, L. Cantone, P. Apostoli, P. A. Bertazzi, A. A. Baccarelli, Blood hypomethylation of inflammatory genes mediates the effects of metal-rich airborne pollutants on blood coagulation, Occupational and Environmental Medicine, 2013, 70, 6, 418

    CrossRef

  27. 27
    Susan V. Mallett, Pratima Chowdary, Andrew K. Burroughs, Clinical utility of viscoelastic tests of coagulation in patients with liver disease, Liver International, 2013, 33, 7
  28. 28
    Armando Tripodi, Veena Chantarangkul, Francesca Gianniello, Marigrazia Clerici, Laura Lemma, Lidia Padovan, Loredana Gatti, Pier Mannuccio Mannucci, Flora Peyvandi, Global coagulation in myeloproliferative neoplasms, Annals of Hematology, 2013, 92, 12, 1633

    CrossRef

  29. 29
    O. Segers, P. Simioni, D. Tormene, E. Castoldi, Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes, Thrombosis and Haemostasis, 2013, 111, 3, 438

    CrossRef

  30. 30
    Roza Chaireti, Cecilia Jennersjö, Tomas L. Lindahl, Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up, Thrombosis Research, 2013, 131, 2, 135

    CrossRef

  31. 31
    Jong Cheol Jeong, Ji-Eun Kim, Ji Won Ryu, Kwon Wook Joo, Hyun Kyung Kim, Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: Hypercoagulability in patients with vascular access thrombosis, Thrombosis Research, 2013, 132, 5, 604

    CrossRef

  32. 32
    P. A. Kyrle, L. Eischer, Predicting the risk of recurrent venous thromboembolism, Hämostaseologie, 2013, 33, 3

    CrossRef

  33. You have free access to this content33
    S. C. Cannegieter, A. Hylckama Vlieg, Venous thrombosis: understanding the paradoxes of recurrence, Journal of Thrombosis and Haemostasis, 2013, 11,
  34. 34
    Anna Paola Cellai, Donatella Lami, Sandra Fedi, Rossella Marcucci, Lucia Mannini, Caterina Cenci, Angela Rogolino, Andrea Sodi, Ugo Menchini, Rosanna Abbate, Domenico Prisco, A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion, Atherosclerosis, 2012, 224, 1, 97

    CrossRef

  35. 35
    Yesim Dargaud, Alisa S. Wolberg, Roger Luddington, Veronique Regnault, Henri Spronk, Trevor Baglin, Thomas Lecompte, Hugo Ten Cate, Claude Negrier, Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study, Thrombosis Research, 2012, 130, 6, 929

    CrossRef

  36. 36
    Christopher Bombardier, Elizabeth Villalobos-Menuey, Katherine Ruegg, William E. Hathaway, Marilyn J. Manco-Johnson, Neil A. Goldenberg, Monitoring hypercoagulability and hypofibrinolysis following acute venous Thromboembolism in Children: Application of the CloFAL assay in a prospective inception cohort study, Thrombosis Research, 2012, 130, 3, 343

    CrossRef

  37. 37
    Paul B. Massion, Pierre Peters, Didier Ledoux, Valentine Zimermann, Jean-Luc Canivet, Pierre P. Massion, Pierre Damas, André Gothot, Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation, Intensive Care Medicine, 2012, 38, 8, 1326

    CrossRef

  38. 38
    Katerina Lejhancova-Tousovska, Ondrej Zapletal, Sona Vytiskova, Petra Strbackova, Jaroslav Sterba, Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin–Frankfurt–Münster (BFM) protocols, Blood Coagulation & Fibrinolysis, 2012, 23, 2, 144

    CrossRef

  39. 39
    Gualtiero Palareti, Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It, Scientifica, 2012, 2012, 1

    CrossRef

  40. 40
    Hugo ten Cate, Thrombin generation in clinical conditions, Thrombosis Research, 2012, 129, 3, 367

    CrossRef

  41. 41
    Fred J. L. M. Haas, Roger E. G. Schutgens, Cornelis Kluft, Douwe H. Biesma, A thrombin generation assay may reduce the need for compression ultrasonography for the exclusion of deep venous thrombosis in the elderly, Scandinavian Journal of Clinical and Laboratory Investigation, 2011, 71, 1, 12

    CrossRef

  42. 42
    Armando Tripodi, Adriana Branchi, Veena Chantarangkul, Marigrazia Clerici, Giuliana Merati, Andrea Artoni, Pier Mannuccio Mannucci, Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay, Journal of Thrombosis and Thrombolysis, 2011, 31, 2, 165

    CrossRef

  43. 43
    Fred J.L.M. Haas, Cornelis Kluft, Douwe H. Biesma, Roger E.G. Schutgens, Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay, Blood Coagulation & Fibrinolysis, 2011, 22, 6, 506

    CrossRef

  44. 44
    B.A.L. Owen, A. Xue, J.A. Heit, W.G. Owen, Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism, Thrombosis Research, 2011, 127, 1, 39

    CrossRef

  45. 45
    Astrid Bergrem, Anders Erik Astrup Dahm, Anne Flem Jacobsen, Marie-Christine Mowinckel, Leiv Sandvik, Per Morten Sandset, Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism, British Journal of Haematology, 2011, 154, 2
  46. 46
    K. Sonnevi, S. N. Tchaikovski, M. Holmström, J. Rosing, K. Bremme, G. Lärfars, Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18–65 years, Thrombosis and Haemostasis, 2011, 106, 5, 901

    CrossRef

  47. 47
    Elisabetta Castoldi, Jan Rosing, Thrombin generation tests, Thrombosis Research, 2011, 127, S21

    CrossRef

  48. 48
    Francisco Buitrago Ramírez, José Antonio Morales Gabardino, Javier Alejandre Carmona, Tratamiento y prevención secundaria del tromboembolismo, FMC - Formación Médica Continuada en Atención Primaria, 2011, 18, 6, 366

    CrossRef

  49. 49
    TREVOR BAGLIN, Using the laboratory to predict recurrent venous thrombosis, International Journal of Laboratory Hematology, 2011, 33, 4
  50. 50
    Armando Tripodi, Cristina Legnani, Laura Lemma, Benilde Cosmi, Gualtiero Palareti, Veena Chantarangkul, Pier Mannuccio Mannucci, Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism, Journal of Thrombosis and Thrombolysis, 2010, 30, 2, 215

    CrossRef

  51. 51
    Giuseppe Lippi, Gianfranco Cervellin, Massimo Franchini, Emmanuel J. Favaloro, Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future, Journal of Thrombosis and Thrombolysis, 2010, 30, 4, 459

    CrossRef

  52. 52
    A. GATT, A. RIDDELL, V. CALVARUSO, E. G. TUDDENHAM, M. MAKRIS, A. K. BURROUGHS, Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy, Journal of Thrombosis and Haemostasis, 2010, 8, 9
  53. 53
    M. ALHENC-GELAS, M. CANONICO, V. PICARD, Influence of natural SERPINC1 mutations on ex vivo thrombin generation, Journal of Thrombosis and Haemostasis, 2010, 8, 4
  54. 54
    Rolf Jorde, Monica Sneve, Peter Torjesen, Yngve Figenschau, John-Bjarne Hansen, Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D, Thrombosis Research, 2010, 125, 5, e210

    CrossRef

  55. 55
    Gregor Hron, Paul A. Kyrle, Alexandra Kaider, Karl Philipp, Ingrid Pabinger, Marietta Kollars, Sabine Eichinger, ProCGlobal and endogenous thrombin potential during pregnancy, American Journal of Obstetrics and Gynecology, 2010, 203, 5, 463.e1

    CrossRef

  56. 56
    Paul Alexander Kyrle, Frits R Rosendaal, Sabine Eichinger, Risk assessment for recurrent venous thrombosis, The Lancet, 2010, 376, 9757, 2032

    CrossRef

  57. 57
    C. N. BAGOT, M. S. MARSH, M. WHITEHEAD, R. SHERWOOD, L. ROBERTS, R. K. PATEL, R. ARYA, The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy, Journal of Thrombosis and Haemostasis, 2010, 8, 8
  58. 58
    T. BAGLIN, Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic state, Journal of Thrombosis and Haemostasis, 2010, 8, 2
  59. 59
    Noppacharn Uaprasert, Peter M. Voorhees, Nigel Mackman, Nigel S. Key, Venous thromboembolism in multiple myeloma: Current perspectives in pathogenesis, European Journal of Cancer, 2010, 46, 10, 1790

    CrossRef

  60. 60
    S. EICHINGER, P. A. KYRLE, Duration of anticoagulation after initial idiopathic venous thrombosis – the swinging pendulum: Risk assessment to predict recurrence, Journal of Thrombosis and Haemostasis, 2009, 7,
  61. 61
    Y. Buyue, J. P. Sheehan, Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite, Blood, 2009, 114, 14, 3092

    CrossRef

  62. 62
    A. TRIPODI, C. LEGNANI, G. PALARETI, V. CHANTARANGKUL, P. M. MANNUCCI, More on: high thrombin generation and the risk of recurrent venous thromboembolism, Journal of Thrombosis and Haemostasis, 2009, 7, 5
  63. 63
    P. L. LUTSEY, A. R. FOLSOM, S. R. HECKBERT, M. CUSHMAN, Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study, Journal of Thrombosis and Haemostasis, 2009, 7, 10
  64. 64
    K. MEIJER, S. SCHULMAN, The absence of `minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios, Journal of Thrombosis and Haemostasis, 2009, 7, 10
  65. 65
    Jeffrey I. Weitz, Unanswered questions in venous thromboembolism, Thrombosis Research, 2009, 123, S2

    CrossRef